This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract, valued at $6,446.59, has an ultimate completion date of November 7, 2024. It is part of DLA's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00, which enables the company to provide a wide range of medical products and supplies to support U.S. Armed Forces medical operations. This contract is an unrestricted, non-set-aside award.
Generated 2/5/25, 9:24 AM